Skip to main content
Clinical Trials/ACTRN12609000996268
ACTRN12609000996268
Completed
Phase 4

Randomized prospective trial of cyclosporine with/without low-dose prednisolone in idiopathic membranous nephropathy in adults with nephrotic syndrome

Research Group for Treatments of Kidney Diseases in Ibaraki, Japan0 sites30 target enrollmentMarch 31, 2006

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Research Group for Treatments of Kidney Diseases in Ibaraki, Japan
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2006
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Research Group for Treatments of Kidney Diseases in Ibaraki, Japan

Eligibility Criteria

Inclusion Criteria

  • Biopsy proven idiopathic membranous nephropathy.
  • Over 3\.5 g/day of excretion of urinary protein.

Exclusion Criteria

  • Secondary forms of membranous nephropathy.
  • Less than 70 ml/min of creatinine clearance.
  • Patients with relapse or recurrence.
  • Treated with other immunosuppressants.

Outcomes

Primary Outcomes

Not specified

Similar Trials